Neurones (NRO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Neurones (NRO) has a cash flow conversion efficiency ratio of 0.144x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€67.10 Million ≈ $78.45 Million USD) by net assets (€464.87 Million ≈ $543.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NRO cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Neurones - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Neurones's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Neurones Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neurones ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sharda Cropchem Limited
NSE:SHARDACROP
|
0.226x |
|
Standard Lithium Ltd
NYSE MKT:SLI
|
-0.016x |
|
Appian Corp
NASDAQ:APPN
|
-0.828x |
|
Empire State Realty Trust Inc
NYSE:ESRT
|
0.059x |
|
Vertex
NASDAQ:VERX
|
0.154x |
|
Asseco South Eastern Europe S.A.
WAR:ASE
|
0.038x |
|
CureVac NV
F:5CV
|
0.034x |
|
Zhang Jia Jie Tourism Group Co Ltd
SHE:000430
|
0.022x |
Annual Cash Flow Conversion Efficiency for Neurones (2000–2025)
The table below shows the annual cash flow conversion efficiency of Neurones from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Neurones market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €464.87 Million ≈ $543.48 Million |
€80.77 Million ≈ $94.43 Million |
0.174x | -10.19% |
| 2024-12-31 | €436.17 Million ≈ $509.93 Million |
€84.38 Million ≈ $98.65 Million |
0.193x | +9.49% |
| 2023-12-31 | €407.91 Million ≈ $476.89 Million |
€72.08 Million ≈ $84.26 Million |
0.177x | +20.73% |
| 2022-12-31 | €375.58 Million ≈ $439.09 Million |
€54.97 Million ≈ $64.26 Million |
0.146x | -19.92% |
| 2021-12-31 | €352.92 Million ≈ $412.60 Million |
€64.50 Million ≈ $75.40 Million |
0.183x | -2.49% |
| 2020-12-31 | €359.02 Million ≈ $419.74 Million |
€67.29 Million ≈ $78.67 Million |
0.187x | +0.04% |
| 2019-12-31 | €327.32 Million ≈ $382.67 Million |
€61.32 Million ≈ $71.69 Million |
0.187x | +78.45% |
| 2018-12-31 | €295.88 Million ≈ $345.91 Million |
€31.06 Million ≈ $36.31 Million |
0.105x | +20.94% |
| 2017-12-31 | €268.05 Million ≈ $313.38 Million |
€23.27 Million ≈ $27.20 Million |
0.087x | -1.91% |
| 2016-12-31 | €238.46 Million ≈ $278.78 Million |
€21.10 Million ≈ $24.67 Million |
0.088x | -36.47% |
| 2015-12-31 | €215.75 Million ≈ $252.23 Million |
€30.05 Million ≈ $35.13 Million |
0.139x | -4.12% |
| 2014-12-31 | €196.88 Million ≈ $230.17 Million |
€28.60 Million ≈ $33.44 Million |
0.145x | +27.13% |
| 2013-12-31 | €175.21 Million ≈ $204.84 Million |
€20.02 Million ≈ $23.41 Million |
0.114x | -7.69% |
| 2012-12-31 | €155.42 Million ≈ $181.70 Million |
€19.24 Million ≈ $22.49 Million |
0.124x | +107.58% |
| 2011-12-31 | €139.13 Million ≈ $162.65 Million |
€8.30 Million ≈ $9.70 Million |
0.060x | -51.07% |
| 2010-12-31 | €121.33 Million ≈ $141.84 Million |
€14.79 Million ≈ $17.29 Million |
0.122x | -15.41% |
| 2009-12-31 | €108.28 Million ≈ $126.59 Million |
€15.60 Million ≈ $18.24 Million |
0.144x | -16.44% |
| 2008-12-31 | €96.91 Million ≈ $113.30 Million |
€16.71 Million ≈ $19.54 Million |
0.172x | -3.49% |
| 2007-12-31 | €85.89 Million ≈ $100.41 Million |
€15.35 Million ≈ $17.94 Million |
0.179x | +224.85% |
| 2006-12-31 | €76.51 Million ≈ $89.45 Million |
€4.21 Million ≈ $4.92 Million |
0.055x | -30.38% |
| 2005-12-31 | €70.65 Million ≈ $82.60 Million |
€5.58 Million ≈ $6.52 Million |
0.079x | -31.98% |
| 2004-12-31 | €64.70 Million ≈ $75.64 Million |
€7.51 Million ≈ $8.78 Million |
0.116x | +83473.39% |
| 2003-12-31 | €58.96 Million ≈ $68.93 Million |
€8.19K ≈ $9.58K |
0.000x | +22.21% |
| 2002-12-31 | €54.11 Million ≈ $63.26 Million |
€6.15K ≈ $7.19K |
0.000x | -99.94% |
| 2001-12-31 | €47.97 Million ≈ $56.08 Million |
€9.20 Million ≈ $10.76 Million |
0.192x | +142.91% |
| 2000-12-31 | €42.63 Million ≈ $49.84 Million |
€3.37 Million ≈ $3.94 Million |
0.079x | -- |
About Neurones
Neurones S.A. provides infrastructure, application, and consulting services in France. The company offers cloud, infrastructure management, DevOps, cybersecurity, user support, IT service management, information system governance, and automation services. It also provides digital, UX/UI, agile, devOps, mobility, and data; SAP integration and outsourcing content management, business process manage… Read more